Sharp Mesa Vista Hospital is enrolling both men and women ages 50 to 90 for studies of investigational medicines for Alzheimer's disease and mild cognitive impairment. To qualify, you must:

• Attend study visits at Sharp Mesa Vista Hospital's Clinical Research Center
• Have a caregiver (spouse, relative or health care aide) who can accompany you to study visits and help monitor your study progress

About these studies.

TauRx

This study is for people who have been diagnosed with mild Alzheimer's disease and are not currently taking any medications for Alzheimer's. The study will last for six months and participants will receive either an investigational drug (TRx0237) or a placebo. The study will assess the safety and effectiveness of TRx0237 and determine if the investigational drug will slow the disease progression

Learn more about this study.

BAN2401

This study is for people who have experienced gradual memory changes for at least six months and who may have been diagnosed with mild cognitive impairment or mild Alzheimer's disease. The study will last for approximately a year and a half and participants will receive the study drug (BAN2401) or a placebo. This study will test the effectiveness of different doses of the experimental drug BAN2401 as a possible treatment for people with mild cognitive impairment or mild Alzheimer's disease.

How to enroll.

To learn more or to enroll in a clinical trial, call 858-836-8350 or send us an email.

Participation is confidential and trials are safely conducted under the supervision of experienced physicians and research specialists. Eligible participants may be compensated for time and travel. Transportation to and from study visits can be provided upon request.